THE WHY HOW DO COMPANY, Inc. Logo

THE WHY HOW DO COMPANY, Inc.

A corporate regeneration platform for business turnarounds, M&A, and succession solutions.

3823 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
新宿区愛住町22
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

THE WHY HOW DO COMPANY, Inc. operates a multifaceted 'corporate regeneration platform' focused on fostering mutual growth for companies and their personnel. The company's strategic business model centers on three core areas: conventional business turnarounds, innovative 'non-sale business succession' solutions, and functioning as a 'business model general trading company.' Through these services, it aims to establish a unique position as a comprehensive developer within the M&A industry, prioritizing value creation and sustainable growth. Historically known as Acrodea Inc., its operations also encompass software development, IoT solutions, and entertainment-related businesses.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-07-16 09:08
Board/Management Information
臨時報告書
Japanese 21.7 KB
2025-07-14 09:46
Legal Proceedings Report
臨時報告書
Japanese 18.9 KB
2025-05-27 09:37
Board/Management Information
臨時報告書
Japanese 19.4 KB
2025-04-14 08:49
Regulatory News Service
臨時報告書
Japanese 19.6 KB
2025-04-14 08:47
Report Publication Announcement
確認書
Japanese 8.1 KB
2025-04-14 08:45
Interim Report
半期報告書-第21期(2024/09/01-2025/08/31)
Japanese 294.3 KB
2025-01-29 07:42
Regulatory News Service
臨時報告書
Japanese 18.3 KB
2025-01-14 08:09
Regulatory News Service
臨時報告書
Japanese 19.4 KB
2024-11-29 08:43
Post-Annual General Meeting Information
臨時報告書
Japanese 20.1 KB
2024-11-29 08:41
Registration Form
確認書
Japanese 8.1 KB
2024-11-29 08:40
Governance Information
内部統制報告書-第20期(2023/09/01-2024/08/31)
Japanese 25.1 KB
2024-11-29 08:37
Annual Report
有価証券報告書-第20期(2023/09/01-2024/08/31)
Japanese 1.3 MB
2024-11-13 07:32
Annual Report
訂正有価証券報告書-第15期(2018/09/01-2019/08/31)
Japanese 1.4 MB
2024-10-18 10:13
Regulatory News Service
臨時報告書
Japanese 20.9 KB
2024-08-15 08:22
Regulatory News Service
訂正有価証券報告書-第15期(2018/09/01-2019/08/31)
Japanese 675.6 KB

Automate Your Workflow. Get a real-time feed of all THE WHY HOW DO COMPANY, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for THE WHY HOW DO COMPANY, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Innovation Inc. Logo
Drives B2B growth via digital media, IT solutions, M&A advisory, and venture capital.
Japan 3970
INTAGE HOLDINGS Inc. Logo
Marketing research & business intelligence for consumer goods, healthcare & enterprise tech.
Japan 4326
IntegraGen Logo
Genomic analysis & molecular diagnostics for cancer and rare diseases for researchers and labs.
France ALINT
Interworks Confidence Inc. Logo
Specialized staffing and recruitment for the game, entertainment, and manufacturing sectors.
Japan 7374
INTLOOP Inc. Logo
Offers consulting, tech, and HR solutions leveraging a vast freelance professional network.
Japan 9556
IntoCell, Inc. Logo
Develops and licenses proprietary ADC platform technologies for cancer & immune therapies.
South Korea 287840
Intracom S.A. Holdings Logo
A multinational group delivering IT solutions, defense electronics, and construction projects.
Greece INTRK
Inventionmed Spolka Akcyjna Logo
Develops VR medical simulators with haptic feedback for dermatology training.
Poland INM
Inventiva Logo
Clinical-stage biopharma developing oral therapies for fibrosis, oncology, & lysosomal disorders.
France IVA
A CRO advancing precision medicine via genomic analysis and clinical trial support services.
South Korea 216400

Talk to a Data Expert

Have a question? We'll get back to you promptly.